Skip to Main Content
Table 1—

Baseline characteristics of hypertensive patients with and without diabetes

DiabeticNondiabeticP
n 274 526  
Age (years) 65.9 ± 8.3 65.3 ± 9.5 0.40 
Duration of hypertensive (years) 12.9 ± 5.2 12.4 ± 5.4 0.28 
Nonwhite race (%) 32 (11.7) 35 (6.7) 0.01 
Number of antihypertensive medications (%)    
 0 27 (9.8) 41 (7.8) 0.32 
 1 81 (29.6) 183 (34.8)  
 2 85 (31.0) 169 (32.1)  
 ≥3 81 (29.6) 133 (25.3)  
Selected coexisting conditions (%)    
 Coronary artery disease 117 (42.7) 180 (34.2) 0.02 
 Cerebrovascular disease 29 (10.6) 58 (11.0) 0.85 
 Hyperlipidemia 65 (23.7) 140 (26.6) 0.37 
BMI (kg/m229.2 ± 4.8 27.8 ± 4.3 <0.001 
n 245 437  
DiabeticNondiabeticP
n 274 526  
Age (years) 65.9 ± 8.3 65.3 ± 9.5 0.40 
Duration of hypertensive (years) 12.9 ± 5.2 12.4 ± 5.4 0.28 
Nonwhite race (%) 32 (11.7) 35 (6.7) 0.01 
Number of antihypertensive medications (%)    
 0 27 (9.8) 41 (7.8) 0.32 
 1 81 (29.6) 183 (34.8)  
 2 85 (31.0) 169 (32.1)  
 ≥3 81 (29.6) 133 (25.3)  
Selected coexisting conditions (%)    
 Coronary artery disease 117 (42.7) 180 (34.2) 0.02 
 Cerebrovascular disease 29 (10.6) 58 (11.0) 0.85 
 Hyperlipidemia 65 (23.7) 140 (26.6) 0.37 
BMI (kg/m229.2 ± 4.8 27.8 ± 4.3 <0.001 
n 245 437  

Data are means ± SD and n (%).

Close Modal

or Create an Account

Close Modal
Close Modal